HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins

Citation
Pm. Dansette et al., HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins, EXP TOX PAT, 52(2), 2000, pp. 145-148
Citations number
23
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
ISSN journal
09402993 → ACNP
Volume
52
Issue
2
Year of publication
2000
Pages
145 - 148
Database
ISI
SICI code
0940-2993(200005)52:2<145:HRAIHL>2.0.ZU;2-Q
Abstract
The aim of this study was to compare a number of vastatins, HMG-CoA reducta se inhibitors, in human liver microsomes. HMG-CoA reductase activity was fo ur times lower than the activity in untreated rat liver microsomes. Vastati ns could be classified in this in vitro assay in three classes both in huma n and rat microsomes: the first one including cerivastatin with an IC50 of 6 nM, the second one with atorvastatin and fluvastatin (IC50) between 40 an d 100 nM) and the third one containing pravastatin, simvastatin and lovasta tin (IC50 between 100 and 300 nM).